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Comment
The title compound ( Fig. 1 ) was prepared by lateral metalation with lithium hexamethyldisilazide and electrophilic quenching with benzyl bromide (Natale & Mirzaei, 1993) , under thermodynamic conditions (Niou & Natale, 1986; Schlicksupp & Natale, 1987) , during which a facile second deprotonation and quenching leads to double incorporation (Natale et al., 1985 , Natale & Niou, 1984 . Mono-alkylation and recovered starting material account for sufficient material balance to rule out substantial rearrangement under these conditions. The present study unambiguously establishes the regiochemistry of double alkylation. Previous reports on analogous deprotonation with sodium alkoxides (Dal Piaz, et al., 1975; Chimichi, et al., 1986) , reported rearrangement to pyrazoles with longer reaction times (Dal Piaz et al., 1985) . The lateral metalation and electrophilic quenching of isoxazoles continues to lead to candidates with promising biological activity (Nakamura, et al., 2010; Hulubei et al., 2012) and is the subject of active investigation, to be reported in due course. The conformation observed in the solid state ( Fig. 1 ) would be expected to result in magnetic anisotropy if maintained in solution, and this is indeed observed, as the 1 H NMR resonance of the C(4) methyl is observed at δ 2.55 in the starting material, δ 2.21 in the monoalkylated product, and δ 1.86 in the title compound. Further chemistry and pharmacology studies based upon this reaction are underway and will be reported in due course.
Experimental
Starting material, 3-methyl-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one ( Fig. 2 ) was prepared according to Renzi and Dal Piaz (1965) . To starting material (88 mg, 0.36 mmol) was added freshly distilled tetrahydrofuran (THF, 25 ml), under an argon atmosphere. The temperature was lowered to 195 K, and a solution of lithium hexamethyldisilazide
(1 ml, 1.0M in THF, Aldrich, 28% excess) was added dropwise over five minutes. After stirring for 1 h, benzyl bromide was added via syringe (0.1 ml, 0.84 mmol, 14% excess). The reaction was allowed to come to room temperature with stirring overnight, after which time the solvent was removed in vacuo by rotary evaporator, and the residue chromatographed on an 80 x 35 cm silica gel column. Gradient chromatogrpahy was performed beginning with chloroform-hexane (1:1), and the gradient slowly increased in polarity to ethyl acetate (EtOAc)-hexane-chloroform (1:2:1). The product 3-(1,3-diphenylpropan-2-yl)-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one was obtained from the column fraction with R f 0.6 (SiO2, EtOAc-hexane-chloroform 2:1:1) as a solid (57.1 mg, 38% yield), and was recrystallized by slow evaporation from EtOAc/hexanes to which a small amount of heptane had been added. The resulting crystals were used in the single crystal X-ray study. A clear light yellow prism-like specimen was selected for the X-ray data collection with a Bruker D8 Venture PHOTON 100 CMOS system equipped with a Cu K α INCOATEC micro-focus source (λ = 1.54178 Å).
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Refinement
A DELU restraint (Sheldrick, 2008) was used for the U ij of all non-H atoms. Hydrogen atoms were positioned geometrically and refined as riding atoms, with C-H = 0.96-0.99 Å and U iso (H) = 1.5U eq (C) for methyl H atoms, and U iso (H) = 1.2U eq (C) for all other H atoms.
Computing details
Data collection: SMART (Bruker, 2012) ; cell refinement: SAINT (Bruker, 2012) ; data reduction: SAINT (Bruker, 2012) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: Mercury (Macrae et al., 2008) ; software used to prepare material for publication:
publCIF (Westrip, 2010) .
Figure 1
Molecular structure of the title compound, with H atoms represented by small spheres of arbitrary radius and displacement ellipsoids at the 50% probability level.
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Figure 2
Benzylation of 3-methyl-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one as precursor to give the title compound.
Figure 3
The unit cell of the title compound. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
3-(1,3-Diphenylpropan-2-yl)-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one
R int = 0.017 θ max = 66.6°, θ min = 2.8°h = −8→3 k = −11→11 l = −18→18 Refinement Refinement on F 2 Least-squares matrix: full R[F 2 > 2σ(F 2 )] = 0.032 wR(F 2 ) = 0.078 S = 1.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq O1 0.00502 (11) 0.47448 (8) C3 0.0203 (5) 0.0218 (5) 0.0249 (5) −0.0074 (4) −0.0030 (4) 0.0017 (4) C4 0.0218 (5) 0.0200 (5) 0.0229 (5) −0.0075 (4) −0.0013 (4) 0.0021 (4) C5 0.0232 (5) 0.0241 (5) 0.0236 (5) −0.0094 (4) −0.0042 (4) 0.0017 (4) C6 0.0216 (5) 0.0163 (5) 0.0296 (5) −0.0063 (4) −0.0059 (4) 0.0031 (4) C7 0.0282 (6) 0.0219 (5) 0.0261 (5) −0.0065 (4) −0.0039 (4) 0.0013 (4) C8 0.0244 (5) 0.0222 (5) 0.0336 (6) −0.0045 (4) −0.0011 (4) −0.0012 (4) C9 0.0241 (5) 0.0215 (5) 0.0383 (6) −0.0049 (4) −0.0097 (4) 0.0030 (4) C10 0.0300 (6) 0.0238 (5) 0.0283 (6) −0.0083 (4) −0.0089 (4) 0.0037 (4) C11 0.0249 (5) 0.0219 (5) 0.0273 (5) −0.0081 (4) −0.0027 (4) 0.0013 (4) C12 0.0243 (5) 0.0244 (6) 0.0389 (6) −0.0051 (4) −0.0086 (5) −0.0052 (5) C13 0.0237 (5) 0.0230 (5) 0.0295 (6) −0.0065 (4) −0.0082 (4) 0.0033 (4) (9) C18-C17-C16 120.33 (10) C4-C3-C12 123.07 (9) C18-C17-H17 119.8 C5-C4-C1 104.21 (9) C16-C17-H17 119.8 C5-C4-C3 136.51 (10) C17-C18-C19 119.48 (11) C1-C4-C3 119.28 (9) C17-C18-H18 120.3 O1-C5-C4 108.15 (9) C19-C18-H18 120.3 O1-C5-C13 115.96 (9) C20-C19-C18 120.14 (11) C4-C5-C13 135.89 (10) C20-C19-H19 119.9 C7-C6-C11 121.11 (10) C18-C19-H19 119.9 C7-C6-N2 119.36 (9) C19-C20-C15 120.97 (10) C11-C6-N2 119.33 (9) C19-C20-H20 119.5 C6-C7-C8 119.17 (10) C15-C20-H20 119.5 C6-C7-H7 120.4 C27-C21-C13 110.58 (9) C8-C7-H7 120.4 C27-C21-H21A 109.5 C9-C8-C7 120.33 (10) C13-C21-H21A 109.5 C9-C8-H8 119.8 C27-C21-H21B 109.5 C7-C8-H8 119.8 C13-C21-H21B 109.5 C8-C9-C10 119.94 (10) H21A-C21-H21B 108.1 C8-C9-H9 120.0 C23-C22-C27 121.42 (11) C10-C9-H9 120.0 C23-C22-H22 119.3 C9-C10-C11 120.40 (10) C27-C22-H22 119.3 C9-C10-H10 119.8 C24-C23-C22 119.85 (11) C11-C10-H10 119.8 C24-C23-H23 120.1 C6-C11-C10 119.05 (10) C22-C23-H23 120.1 C6-C11-H11 120.5 C25-C24-C23 119.42 (11) C10-C11-H11 120.5 C25-C24-H24 120.3 C3-C12-H12A 109.5 C23-C24-H24 120.3 Symmetry codes: (i) −x, −y+1, −z+1; (ii) −x+1, −y+1, −z+1; (iii) −x, −y+1, −z+2.
